PDPN, podoplanin, 10630

N. diseases: 256; N. variants: 3
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2487628
rs2487628
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0005890
Disease:
Body Height 		0.700 GeneticVariation GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
dbSNP: rs374052197
rs374052197
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0006118
Disease:
Brain Neoplasms 		0.010 GeneticVariation BEFREE Patients/Methods In a prospective cohort study, intratumoral IDH1 R132H mutation and podoplanin were determined in brain tumor specimens (mainly glioma) by immunohistochemistry. 29676036 2018
dbSNP: rs374052197
rs374052197
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Patients/Methods In a prospective cohort study, intratumoral IDH1 R132H mutation and podoplanin were determined in brain tumor specimens (mainly glioma) by immunohistochemistry. 29676036 2018
dbSNP: rs745934102
rs745934102
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0006118
Disease:
Brain Neoplasms 		0.010 GeneticVariation BEFREE Patients/Methods In a prospective cohort study, intratumoral IDH1 R132H mutation and podoplanin were determined in brain tumor specimens (mainly glioma) by immunohistochemistry. 29676036 2018
dbSNP: rs745934102
rs745934102
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Patients/Methods In a prospective cohort study, intratumoral IDH1 R132H mutation and podoplanin were determined in brain tumor specimens (mainly glioma) by immunohistochemistry. 29676036 2018
dbSNP: rs374052197
rs374052197
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0017636
Disease:
Glioblastoma 		0.010 GeneticVariation BEFREE Tumors with NF1/Ch17 loss were predominantly adult GBM (4/5); lacked EGFR amplification (0/4), strong p53 immunolabeling (1/5), or IDH1 (R132H) protein expression (0/5); but expressed the mesenchymal marker podoplanin in 4/5. 26190195 2015
dbSNP: rs374052197
rs374052197
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0027651
Disease:
Neoplasms 		0.010 GeneticVariation BEFREE Tumors with NF1/Ch17 loss were predominantly adult GBM (4/5); lacked EGFR amplification (0/4), strong p53 immunolabeling (1/5), or IDH1 (R132H) protein expression (0/5); but expressed the mesenchymal marker podoplanin in 4/5. 26190195 2015
dbSNP: rs374052197
rs374052197
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C1621958
Disease:
Glioblastoma Multiforme 		0.010 GeneticVariation BEFREE Tumors with NF1/Ch17 loss were predominantly adult GBM (4/5); lacked EGFR amplification (0/4), strong p53 immunolabeling (1/5), or IDH1 (R132H) protein expression (0/5); but expressed the mesenchymal marker podoplanin in 4/5. 26190195 2015
dbSNP: rs745934102
rs745934102
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0017636
Disease:
Glioblastoma 		0.010 GeneticVariation BEFREE Tumors with NF1/Ch17 loss were predominantly adult GBM (4/5); lacked EGFR amplification (0/4), strong p53 immunolabeling (1/5), or IDH1 (R132H) protein expression (0/5); but expressed the mesenchymal marker podoplanin in 4/5. 26190195 2015
dbSNP: rs745934102
rs745934102
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C0027651
Disease:
Neoplasms 		0.010 GeneticVariation BEFREE Tumors with NF1/Ch17 loss were predominantly adult GBM (4/5); lacked EGFR amplification (0/4), strong p53 immunolabeling (1/5), or IDH1 (R132H) protein expression (0/5); but expressed the mesenchymal marker podoplanin in 4/5. 26190195 2015
dbSNP: rs745934102
rs745934102
Entrez Id: 10630
Gene Symbol: PDPN
PDPN
CUI: C1621958
Disease:
Glioblastoma Multiforme 		0.010 GeneticVariation BEFREE Tumors with NF1/Ch17 loss were predominantly adult GBM (4/5); lacked EGFR amplification (0/4), strong p53 immunolabeling (1/5), or IDH1 (R132H) protein expression (0/5); but expressed the mesenchymal marker podoplanin in 4/5. 26190195 2015